OneAscent Financial Services’s Stemline Therapeutics, Inc. STML Stock Holding History

OneAscent Financial Services’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20,099	Closed	-$97K	–	194
2020 Q1	$97K	Buy	20,099 +5,265	+35%	+$34.1K	0.07%	145
2019 Q4	$158K	Buy	+14,834	New	+$147K	0.09%	167
2019 Q3	–	Sell	-11,409	Closed	-$175K	–	223
2019 Q2	$175K	Buy	+11,409	New	+$165K	0.12%	200

OneAscent Financial Services's STML Position: Q2 2020 in Review

OneAscent Financial Services sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 20,099 shares — an estimated $97K sold.

OneAscent Financial Services first reported a position in STML in Q2 2019 and held it in 3 quarters. The position peaked at $175K in Q2 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

OneAscent Financial Services reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
OneAscent Financial Services sold 20,099 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $97K.
OneAscent Financial Services first reported a position in Stemline Therapeutics, Inc. in Q2 2019 and held it in 3 quarters.
OneAscent Financial Services's Stemline Therapeutics, Inc. position peaked at $175K in Q2 2019.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on OneAscent Financial Services's 13F filing for Q2 2020, filed 21 Jul 2020.